Sign in

CIK 0001725160

  • Non-accelerated filer
  • Smaller reporting company

Zentalis Pharmaceuticals, Inc.

Sign in to watch
Ticker
ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
823607803
Phone
+1 858-263-4333
Business address
10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 24 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-10 Gallagher Cam Director Grant or award +7,595 403,001
2022-02-10 Gallagher Cam Director Grant or award · Stock Option (Right to Buy) +19,245 19,245
2022-02-10 SUN ANTHONY Y President & CEO Grant or award +50,431 1,222,206
2022-02-10 SUN ANTHONY Y President & CEO Grant or award · Stock Option (Right to Buy) +118,319 118,319
2022-02-07 Gallagher Cam Director Sale −2,290 $52.77 $121K 394,913
2022-02-07 Gallagher Cam Director Sale −6,460 $53.51 $346K 388,453
2022-02-07 Gallagher Cam Director Sale −1,250 $54.35 $68K 387,203
2022-02-02 SUN ANTHONY Y President & CEO Sale −8,128 $57.87 $470K 1,174,118
2022-02-02 SUN ANTHONY Y President & CEO Sale −2,343 $58.29 $137K 1,171,775
2022-02-01 SUN ANTHONY Y President & CEO Sale −4,124 $56.81 $234K 1,188,593
2022-02-01 SUN ANTHONY Y President & CEO Sale −3,419 $57.63 $197K 1,185,174
2022-02-01 SUN ANTHONY Y President & CEO Sale −2,828 $58.59 $166K 1,182,346
2022-02-01 SUN ANTHONY Y President & CEO Sale −100 $59.31 $6K 1,182,246
2022-01-20 Voliotis Dimitris SVP, Clinical Development Exercise or conversion +10,000 $18.00 $180K 16,250
2022-01-20 Voliotis Dimitris SVP, Clinical Development Sale −8,343 $60.52 $505K 7,907
2022-01-20 Voliotis Dimitris SVP, Clinical Development Sale −1,657 $61.21 $101K 6,250
2022-01-20 Voliotis Dimitris SVP, Clinical Development Exercise or conversion · Stock Option −10,000 124,949
2022-01-20 Bunker Kevin D. Chief Operating Officer Sale −2,753 $59.17 $163K 187,247
2022-01-20 Bunker Kevin D. Chief Operating Officer Sale −6,537 $60.20 $394K 180,710
2022-01-20 Bunker Kevin D. Chief Operating Officer Sale −710 $61.29 $44K 180,000

Page 12 of 28 · 545 trades